Appointment booking for Dr. Matthew Jones, MD is currently not available.Dr. Matthew Jones, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Matthew Jones, MD (he/him) is a Oncologist in Winchester, VA with over 19 years of experience. What is your opinion of Dr. Matthew Jones, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 19 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Matthew Jones, MD has received over $3,260 which includes payments from the following companies:
$800.12 from Genentech USA, Inc.
$415.13 from E.R. Squibb & Sons, L.L.C.
$337.10 from Celgene Corporation
$175.27 from Novartis Pharmaceuticals Corporation
$159.36 from Amgen Inc.
$143.75 from AstraZeneca Pharmaceuticals LP
$139.03 from Janssen Biotech, Inc.
$129.20 from Pfizer Inc.
$112.35 from Astellas Pharma US Inc
$94.90 from Millennium Pharmaceuticals, Inc.
$86.47 from Seattle Genetics, Inc.
$77.58 from Janssen Pharmaceuticals, Inc
$76.50 from Purdue Pharma L.P.
$54.31 from Eisai Inc.
$50.07 from LILLY USA, LLC
$47.21 from Exelixis Inc.
$42.39 from sanofi-aventis U.S. LLC
$38.22 from Merck Sharp & Dohme Corporation
$28.45 from Daiichi Sankyo Inc.
$26.98 from Incyte Corporation
Payments received by Dr. Matthew Jones, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!